Rezpegaldesleukin
- Generic Name
- Rezpegaldesleukin
A Study of NKTR-358 (LY3471851) in Participants With Systemic Lupus Erythematosus (SLE)
- First Posted Date
- 2018-06-14
- Last Posted Date
- 2023-11-18
- Lead Sponsor
- Nektar Therapeutics
- Target Recruit Count
- 48
- Registration Number
- NCT03556007
- Locations
- 🇺🇸
Investigator Site - Clearwater, Clearwater, Florida, United States
🇺🇸Investigator Site - Great Neck, Great Neck, New York, United States
🇺🇸Investigator Site - La Jolla, La Jolla, California, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath